Mineralys Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Mineralys Therapeutics Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Headquarters city: Radnor
Headquarters state / province: Pennsylvania
Headquarters country: United States
Fiscal year end: December
Ticker symbol: MLYS
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001933414
EIN: 84-1966887

Board of directors

Follow this board

Alexander Asam · Director
Since 2023
Alexander M. Gold · Director
Since 2024
Brian Taylor Slingsby · Director
Since 2023
Daphne Karydas · Director
Since 2023
Derek DiRocco · Director
Since 2023
Glenn Sblendorio · Director
Since 2023
Jon Congleton · Director · Chief Executive Officer
Since 2023
Kristine Peterson · Director
Since 2026
Lonnel Coats · Director
Since 2026
Olivier Litzka · Director
Since 2023
Peter Kolchinsky · Director Overboarded
Since 2023
Rajeev M. Shah · Director Overboarded
Since 2023
Srinivas Akkaraju · Director Overboarded
Since 2023
Takeshi Takahashi · Director
Since 2023

Chief executives

Jon Congleton · Chief Executive Officer

Since February 2023

Director election results

Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Srinivas Akkaraju

60.6%
Daphne Karydas

99.3%

Board connections

9 of this board's directors also sit on 38 other boards. 38 are in the same sector.

Shared director Other board Same sector +22 more in the list below

Acrivon Therapeutics Inc. Same sector
via Derek DiRocco, Peter Kolchinsky and Rajeev M. Shah
Evommune Inc. Same sector
via Derek DiRocco, Peter Kolchinsky and Rajeev M. Shah
Werewolf Therapeutics Inc. Same sector
via Derek DiRocco, Peter Kolchinsky and Rajeev M. Shah
ARS Pharmaceuticals Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Acumen Pharmaceuticals Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Artiva Biotherapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Bambusa Therapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Bicara Therapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Black Diamond Therapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Climb Bio Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Freenome Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Hemab Therapeutics Holdings Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Jade Biosciences Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Janux Therapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
LENZ Therapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Nkarta Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Parabilis Medicines Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
PepGen Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Septerna Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Sionna Therapeutics Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Solid Biosciences Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
SpyGlass Pharma Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Tyra Biosciences Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Vor Biopharma Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
Wave Life Sciences Inc. Same sector
via Peter Kolchinsky and Rajeev M. Shah
4D Molecular Therapeutics Inc. Same sector
via Glenn Sblendorio
Alumis Inc. Same sector
via Srinivas Akkaraju
ArriVent BioPharma Inc. Same sector
via Kristine Peterson
Avalyn Pharma Inc. Same sector
via Jon Congleton
COMPASS Pathways Plc Same sector
via Daphne Karydas
Enanta Pharmaceuticals Inc. Same sector
via Kristine Peterson
Immunic Inc. Same sector
via Jon Congleton
Immunocore Holdings plc Same sector
via Kristine Peterson
Kalaris Therapeutics Inc. Same sector
via Srinivas Akkaraju
Lexicon Pharmaceuticals Inc. Same sector
via Lonnel Coats
Relay Therapeutics Inc. Same sector
via Lonnel Coats
Scholar Rock Holding Corporation Same sector
via Srinivas Akkaraju
vTv Therapeutics Inc. Same sector
via Srinivas Akkaraju

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $8,762,797; 2 purchases by 1 insider
Sold, last 12 months: $72,894,480; 63 sales by 7 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 19, 2026	Lonnel Coats Director	Grant or award	+12,400	—	—
Oct 19, 2026	Kristine Peterson Director	Grant or award	+12,400	—	—
Sep 30, 2026	Jon Congleton Director, Officer (Chief Executive Officer)	Open-market sale	−75,000	$25.46	$1,909,665
Sep 22, 2026	Brian Taylor Slingsby Director	Open-market sale	−104,320	$28.81	$3,005,459
Sep 21, 2026	Warren Eric Officer (Chief Commercial Officer)	Option exercise	+7,438	$13.24	$98,479
Sep 21, 2026	Warren Eric Officer (Chief Commercial Officer)	Open-market sale	−7,438	$28.12	$209,157
Sep 15, 2026	Daphne Karydas Director	Option exercise	+3,000	$12.02	$36,060
Sep 15, 2026	Daphne Karydas Director	Open-market sale	−3,000	$28.58	$85,740
Aug 21, 2026	Warren Eric Officer (Chief Commercial Officer)	Option exercise	+7,437	$13.24	$98,466
Aug 21, 2026	Warren Eric Officer (Chief Commercial Officer)	Open-market sale	−7,437	$25.98	$193,213
Aug 10, 2026	Ferguson James J. III Officer (Chief Medical Officer)	Grant or award	+102,400	—	—
Aug 10, 2026	Rodman David Malcom Officer (Chief Medical Officer)	Option exercise	+2,170	$16.00	$34,720
Aug 10, 2026	Rodman David Malcom Officer (Chief Medical Officer)	Open-market sale	−2,170	$27.09	$58,785
Jul 21, 2026	Warren Eric Officer (Chief Commercial Officer)	Option exercise	+7,438	$13.24	$98,479
Jul 21, 2026	Warren Eric Officer (Chief Commercial Officer)	Open-market sale	−7,438	$26.87	$199,859

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Mineralys Therapeutics Inc.

Who is the CEO of Mineralys Therapeutics Inc.?

Jon Congleton has been Mineralys Therapeutics Inc.'s Chief Executive Officer since February 2023.

How many directors are on Mineralys Therapeutics Inc.'s board?

Mineralys Therapeutics Inc.'s board has 14 directors: Alexander Asam, Alexander M. Gold, Brian Taylor Slingsby, Daphne Karydas, Derek DiRocco, Glenn Sblendorio, Jon Congleton, Kristine Peterson, Lonnel Coats, Olivier Litzka and 4 others.

Are Mineralys Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Mineralys Therapeutics Inc. insiders bought $8.8 million of shares in 2 purchases and sold $72.9 million of shares in 63 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Mineralys Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="mineralys-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.